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Abstract
NF-κB is a well-characterized transcription factor, widely known as a key player in tumor-de-
rived inflammation and cancer development. Herein, we present the functional and molecu-
lar relevance of the canonical NF-κB p65 subunit in nasopharyngeal carcinoma (NPC).
Loss- and gain-of-function approaches were utilized to reveal the functional characteristics
of p65 in propagating tumor growth, tumor-associated angiogenesis, and epithelial-to-mes-
enchymal transition in NPC cells. Extracellular inflammatory stimuli are critical factors that
trigger the NF-κB p65 signaling; hence, we investigated the components of the tumor micro-
environment that might potentially influence the p65 signaling pathway. This led to the iden-
tification of an extracellular matrix (ECM) protein that was previously reported as a
candidate tumor suppressor in NPC. Our studies on the Latent Transforming Growth Fac-
tor-β Binding Protein 2 (LTBP2) protein provides substantial evidence that it can modulate
the p65 transcriptional activity. Re-expression of LTBP2 elicits tumor suppressive effects
that parallel the inactivation of p65 in NPC cells. LTBP2 was able to reduce phosphorylation
of p65 at Serine 536, inhibit nuclear localization of active phosphorylated p65, and impair
the p65 DNA-binding ability. This results in a consequential down-regulation of p65-related
gene expression. Therefore, the data suggest that the overall up-regulation of p65 expres-
sion and the loss of this candidate ECM tumor suppressor are milestone events contributing
to NPC development.
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Introduction
The NF-κB protein family comprises of RelA (p65), RelB, c-Rel, p50 (p105 precursor), and p52
(p100 precursor) [1]. They are characterized by a Rel homology region that allows the subunits
to bind DNA, interact with its inhibitory proteins (IκB proteins), and form homo- or hetero-
dimeric complexes with each other [2,3]. Amidst intense research on the Rel family proteins,
much of our understanding is derived from its evolutionarily conserved immunological signal-
ing pathway. However, there is mounting evidence of its diverse biological roles in influencing
gene expression, cell survival, differentiation, and proliferation [4], while its dysregulation will
ultimately lead to disease causation, and notably, cancer [5–7].
The NF-κB pathway has been closely associated with nasopharyngeal carcinoma (NPC). In
the past decade, studies by a number of investigators concur that NF-κB plays an important
role in NPC development [8–11]. However, to date, limited reports have presented the func-
tional and molecular aspects of the canonical p65 subunit of NF-κB in NPC. The functional
role of this important cancer-associating protein is still largely unclear in NPC. Herein, we pro-
vide comprehensive evidence using genetic manipulation and functional assay approaches to
show that the p65 subunit is indeed a critical player in NPC. In addition, our studies also iden-
tified a possible regulator of p65, which is a putative extracellular matrix (ECM) tumor sup-
pressor gene (TSG), LTBP2, [12] mediating its anti-tumorigenic effects.
The ECM is a major component of the tumor microenvironment, which plays a highly dy-
namic and complex role in tumor development and progression. It modulates the interactions
between extracellular and intracellular circuitry and coordinates cell communication networks
within a tumor mass [13]. Deregulated crosstalk between tumor cells and the ECMmay release
cells from a dormant state, and thereby, lead to detrimental outcomes such as metastasis
[14,15]. The ECM forms a vital structural scaffold within all tissues and organs, while providing
the essential biochemical and biomechanical signals that stimulate and direct tissue morpho-
genesis, differentiation, and homeostasis [16]. Its intricacy and importance can only be appre-
ciated by understanding the diseases that arise when the ECM fails to serve its physiological
purpose [17,18].
Our previous studies identified an ECM protein, LTBP2, as candidate TSG in NPC, since it
has demonstrated significant suppressive effects on NPC tumorigenesis. LTBP2, a 240 kDa ex-
tracellular glycoprotein mapping to chromosome 14q24, belongs to a family of latent TGF-β
binding proteins (LTBPs) that regulates a well-known growth factor, TGF-β [19,20]. Unlike
other family members, LTBP2 does not bind directly to latent TGF-β in the ECM, hence,
highlighting its obscure functions. LTBP2 has been characterized as a regulator of cell adhesion
and elastic fiber assembly by binding to DANCE/fibulin-5 [21,22]. In cancer, Vehvilainen et al
[23] studied the adhesion function of LTBP2 in melanoma cells, while we showed the pleiotro-
pic anti-tumorigenic characteristics of LTBP2 in esophageal squamous cell carcinoma (ESCC)
and NPC through comprehensive functional assay approaches [12,24]. Prior study has also
shown that LTBP2 was down-regulated in all NPC cell lines, attributing to epigenetic modifica-
tion of the gene promoter region [12]. To date, there are no reports on the downstream signal-
ing cascade of LTBP2.
Nevertheless, the genetic basis of this understudied gene remains elusive. This study aims to
1) provide insights into the pathological implications and the underlying molecular mecha-
nisms of the NF-κB p65 subunit in NPC; 2) investigate the biochemical pathways of LTBP2
and examine its modulatory effects on the oncogenic activities of the NF-κB subunit. There-
fore, our finding highlights the significance of the well-established canonical NF-κB pathway
in NPC and demonstrates, for the first time, the communication network between an ECM
protein and its impact on the intracellular signaling cascade in NPC.
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Materials and Methods
Cell lines and culture
The NPC cell line, HONE1, was established from a biopsy specimen from a poorly differentiat-
ed squamous cell carcinoma of the nasopharynx [25,26]. HK1 was established from a recurrent
well-differentiated squamous carcinoma of the nasopharynx of a Chinese male [27]. Both cell
lines were cultured as described previously. Puromycin (InvivoGen, San Diego, CA, USA) was
used as a selection drug for the virally transduced cells. Human umbilical vein endothelial cells
(HUVEC, Cascade Biologics, Portland, OR, USA) were cultured as described [28]. Cell lines
used in this study were genotype authenticated and screened for mycoplasma contamination.
Lentiviral vectors and virus infection
The LTBP2 and red fluorescent protein (RFP)-tagged p65 wild type (WT) genes were cloned
into the lentiviral vector backbone, pLVX-puro with an EF1a promoter. IκBa-super repressor
(SR) gene was cloned into the pWPI lentiviral backbone. The p65- and IκBa-shRNA knock-
down oligonucleotides, designed according to the RNAi consortium library [29], were cloned
into pLKO.1 TRC cloning vector (Addgene plasmid 10878). The sequences of the two shRNA
oligonucleotides are shown in S1 Table. pLKO.1-scramble shRNA vector (Addgene 1864) was
used as a negative control. The IκBa-SR with three HA-tags was obtained from Addgene
(24143) and subcloned into the pWPI system (Addgene plasmid 12254). The co-transfection
system consisted of the respective gene construct, packaging vectors (pCMV-ΔR-8.74 or
psPAX2), and the vesicular stomatitis virus G-protein envelope vector (pMD2G). The con-
struct, packaging vector, and envelope vector were transfected into HEK 293T cells at a ratio of
4:3:1 using Fugene HD transfection reagent (Promega, Madison, WI, USA) according to the
manufacturer’s instructions.
Western blot analysis
Western blot analyses were performed as described previously [30]. Cultured NPC cell lines
were harvested at 70–80% confluence and lysed using RIPA buffer supplemented with protease
inhibitors. The list of antibodies used in this study is summarized in S2 Table.
Subcellular fractionation
Cell lysates were prepared using non-denaturing cell lysis buffer supplemented with protease
inhibitors. Cell organelles were then separated by ultracentrifugation to obtain nuclear and cy-
toplasmic/membrane fractions as described previously [31].
2-Dimensional (2D) and 3-Dimensional (3D) colony formation assay
In the 2D colony formation assay, 3000 transduced cells were seeded onto 6-well plates in trip-
licate and allowed to grow over a span of two weeks. Cells were then fixed with 10% formalin
(Sigma-Aldrich, St. Louis, MO, USA) and stained with 1x diluted Giemsa reagent (Sigma-Al-
drich, St. Louis, MO, USA) to identify cell colonies. The 3D matrigel colony formation assay
was performed as previously described [32]. The 96-well flat bottom plates (NUNC, Thermo
Scientific, Waltham, MA, USA) were first coated with matrigel (BD Biosciences, San Jose, CA,
USA) before being seeded with 200 transduced cells. Colonies were formed over a span of
two weeks.
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Wound healing
The wound healing assay was performed as described [32]. The percentages of wound closure
were calculated based on the formula: (migrated distance of cells after 24 h initial distance of
the wound at 0 h) x 100. All wound healing experiments were conducted in triplicates and the
average percentage wound closure was taken.
Real-time cell migration assays
Real-time cell migration monitoring was conducted using the xCELLigence system (Roche Ap-
plied Science, Penzberg, Upper Bavaria, Germany) following the manufacturer’s protocol. In
brief, 8x104 cells were seeded into each well in the upper chamber of the CIM plate, which was
coated with collagen. The lower chamber containing 10% serum media attracts the cells across
the chambers, which will then be recorded real-time using a RTCA DP analyzer (Roche Ap-
plied Science, Penzberg, Upper Bavaria, Germany).
Cell migration chamber assays
The migration assay was performed as reported previously [33,34]. In brief, 2 x 105 HONE1
cells in serum-free medium were seeded in the top chamber of a BD BioCoat Control 8.0μm
PETMembrane 24-well cell culture insert (BD Biosciences, San Jose, CA, USA). The bottom
chambers were filled with serum-enriched medium that acts as a chemoattractant. Cells were
subsequently stained after 24 hours (migration) with 1% crystal violet. Cells that underwent
migration were counted using an inverted light microscope (Nikon TMS, Ontario, Canada)
and SPOT software 4.6 (Diagnostic Instruments, Sterling Heights, MI, USA).
Human umbilical vein endothelial cell assay
The tube formation assay was conducted as described [28] using vector-alone (VA) and LTBP2
or FBLN2-conditioned media. HUVEC was first serum-starved for one hour prior to being
seeded with 4 x 104 cells into each well of a flat bottom 96-well plate coated with 50μl of matri-
gel. Conditioned media (100μl) from the vector-alone (VA) or gene transfectants were then ap-
plied onto the cells and incubated for 6–8 hours.
Quantitative reverse transcription-polymerase chain reaction
Quantitative RT-PCR analysis was performed on a Step-One Plus PCR machine (Applied Bio-
systems, Life Technology, Carlsbad, CA, USA) as described previously [35]. The SYBR green
PCR core reagent kit (Applied Biosystems, Life Technology, Carlsbad, CA, USA) was used
with gene-specific primers and GAPDH-specific primers as a control. Primers used are sum-
marized in S3 Table.
Immunohistochemistry (IHC)
IHC staining for the CD34 marker (1:100; Santa Cruz Biotechnology, Dallas, TX, USA) on pro-
genitor cells of blood vessels was performed using the standard streptavidin-biotin-peroxidase
complex method as previously reported [30].
Immunofluorescence staining
Transduced HONE1 and HK1 cell lines were fixed in formalin for 10 min and permeabilized
with 0.5% Triton X-100 in PBS as described [33]. The phosphorylated p65 Serine 536 primary
antibody (1:100) was incubated with the cells overnight at 4°C, followed by a FITC-conjugated
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goat anti-rabbit secondary antibody (Sigma-Aldrich, St. Louis, MO, USA) (1:100). Total IκBa
was labeled with Alexa Fluor 546 goat anti-mouse secondary antibody (Molecular Probes, Life
Technology, Carlsbad, CA, USA). Nuclei were stained with DAPI, cells were mounted onto
glass slides with Slowfade Gold Antifade Reagent (Molecular Probes) and viewed under a fluo-
rescence inverted microscope (Nikon Eclipse Ti, Nikon Instruments, Melville, NY, USA) or
confocal microscope (Carl Zeiss LSM 710, Zeiss Microscopy, Jena, Thuringia, Germany).
NF-κB p65 chemiluminescence transcription factor binding assay
The NF-κB/p65 transcription factor binding assay was carried out using the Millipore Univer-
sal EZ-TFA Chemiluminescent Transcription Factor Kit following the manufacturer’s protocol
(Millipore, Billerica, MA, USA).
In vivo tumorigenicity assay
In vivo experiments were conducted as reported previously [36]. Cells were administered via
subcutaneous injection into both flanks of the female BALB/cAnN-nu (nude) mice. In vivo
tumor growth was monitored by measuring the tumor mass at weekly intervals. A total of 1 x
107 cells/site was used for HONE1 and for HK1 cells. Matrigel plug tumors were removed after
one week for IHC staining, while typical tumor mass was monitored over a 2–3 week period.
The mice were sacrificed by cervical dislocation at the end of the experiment. In vivo studies
were conducted with a valid license under the Animals (Control of experiments) Ordinance
from the Department of Health (Hong Kong). The study was specifically approved by the
Committee on the Use of Live Animals in Teaching and Research (CULATR) of the University
of Hong Kong (Approval number: 2501–11).
Statistical analysis
Student’s t-test was performed for all statistical analyses unless stated otherwise. P-
values< 0.05 were considered significant and error bars represent the standard error mean.
Results
NF-κB p65 inactivation inhibits tumorigenicity in vitro and in vivo
The p65 activities were attenuated by utilizing two independent loss-of-function approaches,
i.e. p65 shRNA knockdown and over-expression of IκBα-super repressor (SR) (S1A Fig) in
NPC cells.
Successful p65 knockdown by p65 shRNA was first verified (Fig 1A and S1B Fig). Dimin-
ished colony numbers in in vitro colony formation assay (Fig 1B) and reduced in vivo tumor
growth kinetics in nude mouse models (Fig 1C) proved that the knockdown of p65 elicits
tumor suppressive effects. In addition, the gene expression level of NF-κB related genes such as
MMP3, SOX9, ICAM,MCAM, EGFR, and FN1, were down-regulated upon knocking down
p65 (S1C Fig)
On the other hand, IκBα-SR was over-expressed in NPC cells, as illustrated by Western
blots (Fig 2A). The exogenous IκBα-SR preferentially resides in the cytosol (S1D Fig), which is
analogous to the normal biological localization of endogenous IκBα. Expression of the IκBα-
SR resulted in significant reduction of colony size and numbers (Fig 2B). In vivomouse models
further confirmed the suppressive effects of IκBα-SR (Fig 2C). Furthermore, IκBα-SR-express-
ing cells exhibited a slower migratory potential compared to the pWPI-VA (Fig 2D and 2E),
suggesting that p65 plays an important role in regulating cell motility in NPC. Both indirect
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and direct inactivation of p65 rendered consistent experimental results, thus, providing solid
evidence that p65 is potentially a good target for impeding the growth of NPC cells.
The p65 pathway is involved in tumor-associated angiogenesis by
regulating the pro-angiogenic factors in NPC
The HUVEC tube-formation assay was utilized to examine the pro-angiogenic activity of p65
in NPC. Conditioned media were collected from cells of p65 shRNA knockdown, over-expres-
sion of IκBα-SR, and their corresponding controls to perform HUVEC tube formation assay.
HUVEC tube-forming abilities were largely suppressed by conditioned media collected from
p65 shRNA knockdown- and IκBα-SR- expression (Figs 1D and 2F), possibly due to a
Fig 1. Knockdown of p65 reduces the abilities of in vitro colony formation, in vivo tumor formation, and angiogenesis in NPC. (A)Western blot
analysis shows the transient shRNA-mediated knockdown of p65 in HONE1 cells using shRNA. The p84 serves as a loading control. (B) Two-dimensional
(2D) colony formation assay shows that stable and transient knockdown of p65 reduces the number of colonies formed compared to scramble-transduced
HONE1 cells. Data represented on the bar graph is the average of triplicate experiments ± S.E.M. (C) Nude mice were inoculated subcutaneously with p65
shRNA and scramble HONE1 cells. p65 shRNA-transduced cells showed delayed and reduced tumor growth compared to scramble control cells. Each data
point represents an average tumor volume of six injection sites inoculated for each cell population ± S.E.M. (D) HUVEC tube formation is abrogated with p65
shRNA conditioned medium compared to the scramble control conditioned medium from HONE1 cells. The bar charts indicate data obtained from an
average of triplicate experiments ± S.E.M. The (*) indicates P-value < 0.05 for all graphs.
doi:10.1371/journal.pone.0127239.g001
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reduction in the quantities of pro-angiogenic factors in the media. To further confirm that the
anti-angiogenic activities were attributed to the inactivation of p65, expression levels of pro-an-
giogenic factors were examined (S1B Fig). The down-regulation of p65 (RELA) expression in
p65 knockdown cells was confirmed, when compared with the scramble control cells. IκBα
(NFKBIA), a well-established p65-regulated negative feedback protein, was used as a direct in-
dicator of p65 activity. Since NFKBIA expression was diminished after p65 knockdown, we
then screened a panel of NF-κB angiogenic-related target genes that include IL6, IL8, RANTES,
MCP1, VEGF165, VEGF189, and Total VEGF. Taken together, these findings revealed that the
Fig 2. Inactivation of p65 reduces the abilities of in vitro colony formation, in vivo tumor formation, migration, invasion, and angiogenesis in NPC.
(A)Western blot analysis shows the expression of exogenous IκBα-SR with triple HA-tag (^) in HONE1 cells. The p84 served as a loading control. (B) 2D
colony formation assay shows that IκBα-SR suppressed the colony-forming ability of HONE1 cells compared to pWPI-vector alone (VA). Bar graphs indicate
data obtained from an average of triplicate experiments ± S.E.M. (C) Nude mice were inoculated subcutaneously with IκBα-SR and pWPI-VA HONE1 cells.
IκBα-SR-transduced cells showed delayed and reduced tumor growth kinetics compared to pWPI-VA. Each data point represents an average tumor volume
of six injection sites inoculated for each cell population ± S.E.M. (D)Wound healing analysis for pWPI-VA and IκBα-SR showed delayed migration of IκBα-SR
cells compared to VA. Bar graphs show the percentage difference between IκBα-SR and VA cells ± S.E.M. (E)Migration chamber assays showed that IκBα-
SR-expressing HONE1 cells reduced migration compared to VA cells. Data represented on the bar graph are the average of triplicate experiments ± S.E.M.
(F) HUVEC tube formation was suppressed with IκBα-SR conditioned medium compared to that of VA cells. Data represented on the bar graph are the
average of triplicate experiments ± S.E.M. The (*) for all graphs indicate P-value < 0.05.
doi:10.1371/journal.pone.0127239.g002
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inactivation of p65 in NPC tumor cells reduced the secretion of pro-angiogenic factors, result-
ing in inhibition of angiogenesis.
Enhanced p65 signaling triggers in vitro tumorigenic responses
A two-prong approach in analyzing p65 gain-of-function abilities was conducted. The effects
of p65 activation in NPC were probed by RFP-fusion p65 over-expression and IκBα knock-
down, to eliminate the p65 negative feedback mechanism.
The exogenous RFP-p65 was mainly detected in the cytoplasmic region (Fig 3A). The p65
subunit indeed does appear to promote tumorigenicity, since functional assays showed that
HONE1 RFP-p65 WT-expressing cells possess superior colony-forming abilities (Fig 3B), in-
creased migration (Fig 3C and 3D), and enhanced angiogenesis (Fig 3E).
It is widely known that the endogenous IκBα acts as a tightly-controlled and highly sensitive
feedback mechanism to regulate p65 activities [37]. Hence, to further understand the function
of p65 in NPC, we sought to knockdown IκBα, so as to eliminate its feedback response. Angio-
genic and EMT induction abilities were examined after IκBα inactivation by determining the
expression of a panel of angiogenic factors that include IL6, IL8, Total VEGF, VEGF165,
VEGF189, PDGFB, andMCP1. IκBα knockdown caused a dramatic up-regulation of IL6 and
IL8 expression of up to approximately 41-fold. Expression of Total VEGF, VEGF165,
VEGF189, andMCP1 was elevated by more than 2-fold, whereas PDGFB only showed a slight
increase (S2 Fig). In addition, epithelial markers CDH1, CTNNA1, and CTNNB1 were down-
regulated by approximately 2-fold, whilst mesenchymal markers SNAI2, SNAI1, TWIST1,
VIM, smooth muscle-actin (ACTA2), and SOX9 were significantly up-regulated, and CDH2 ex-
pression was slightly increased. (S3A Fig). Correspondingly, the cell morphology of HONE1
was altered as these epithelial cells undergo mesenchymal transition (S3B Fig).
p65-mediated molecular signaling regulates expression of EGFR and
EMTmarkers
Besides functional approaches, the p65-mediated molecular signaling pathway alterations in
NPC were assessed. Fig 4A shows that the over-expression of IκBα-SR only inhibited the phos-
phorylation of p65 at S536, but did not have significant effect on total p65 expression. This in-
dicates that the IκBα-SR was able to attenuate p65 transcriptional activity without
compromising its overall expression. Nonetheless, both p65 knockdown and IκBα-SR reduced
the expression of N-Cadherin and EGFR (Fig 4A). Conversely, over-expression of RFP-fusion
p65WT induced significant IκBα up-regulation, hence, suggesting that the exogenous p65 pro-
teins are transcriptionally active in HONE1 (Fig 4B). Moreover, exogenous p65 WT protein
showed detectable acetylation at the lysine K310 site, while phosphorylation of endogenous
p65 at S536 was reduced (Fig 4B). This could possibly be due to the increased expression of
IκBα, which serves to regulate the amount of active phosphorylated-p65 in the cell. In addition,
both long and short isoforms of N-Cadherin, and other EMT-related protein expression such
as Snail, Slug, Twist, and Sox9 were elevated following the expression of exogenous p65. Taken
together, these results further support the positive and negative regulatory impact of p65 on
EMT-related protein expression (Fig 4B).
LTBP2 disrupts the activation, nuclear translocation and subsequent
transcriptional activity of NF-κB p65 subunit
The functional and molecular studies suffice to show that the oncogenic p65 requires impor-
tant upstream regulatory mechanisms to modulate its detrimental outcomes in NPC
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development. The candidate ECM tumor suppressor protein, LTBP2, has emerged as a key p65
regulator that has been reportedly lost in all NPC cell lines [12].
Phosphorylation of p65 was found to be reduced in LTBP2-re-expressing NPC cell lines
(Fig 5A). Phosphorylated IKKα/β, which is known to directly phosphorylate p65 at one of the
key serine 536 activation sites [38–40] and the inhibitors of NF-κB (IκBα) [41], were also re-
duced (Fig 5A). A reduction of phospho-IκBαmay result in less IκBα degradation, hence al-
lowing the inhibitor to couple to p65 and suppress its transcriptional activities (Fig 5A).
Moreover, a reduced phospho-p65 level was also observed in Matrigel plugs containing
Fig 3. Enhanced p65 expression promotes in vitro tumorigenic responses. (A) Confocal visualization of cytolocalization of RFP-fusion p65WT (63x
magnification). Scale bar represents 1μm. (B) 2D colony formation assay showed increased number of colonies in p65WT-overexpressing cells compared to
RFP-tagged pLVX-VA cells. Bar graphs show the percentage difference between the number of colonies in p65WT and VA cells ± S.E.M. (C)Migration
chamber assays showed that p65WT-overexpressing HONE1 cells enhanced migration compared to VA cells. Bar graphs illustrate the percentage
difference between the relative migration abilities of p65WT and VA cells ± S.E.M. (D)Wound healing analysis for pLVX-VA and p65WT showed an
increase in migratory potential of p65WT transduced cells compared to VA. Bar graphs show the percentage difference between p65WT and VA cells ± S.E.
M. (E) HUVEC tube formation was augmented with p65WT conditioned media compared to that of VA cells. Bar graphs illustrate the percentage difference
between the tube measurements of p65WT and VA conditioned media-induced HUVEC cells ± S.E.M. The above data were obtained from three
independent experiments and the (*) for all graphs indicate P-value < 0.05.
doi:10.1371/journal.pone.0127239.g003
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LTBP2-expressing HONE1 and HK1 cells (Fig 5B). In particular, total p65 and phospho-p65
were reduced in the nuclear fraction, as determined after subcellular fractionation analysis (Fig
5C).
Immunofluorescence staining of the phospho-p65 showed that the nuclear staining of phos-
pho-p65 was also visibly weaker in LTBP2-re-expressing cells compared to VA (Fig 6A). Utiliz-
ing a chemiluminescence reporter assay specific for NF-κB p65 activity, the DNA binding
Fig 4. p65 signaling pathway regulates the protein expression of EGFR and EMTmarkers. (A)Western blot analysis of p65shRNA- HONE1 cells
showed reduced levels of phosphorylated p65 S536, total p65, and total IκBα compared to scramble control. IκBα-SR- HONE1 cells only showed a
decreased amount of phosphorylated p65 S536, but did not affect the overall amount of total p65 when compared to pWPI-VA. Endogenous and exogenous
IκBα are labeled as shown. The p84 was used as a loading control for scramble and p65 shRNA, pWPI-VA and IκBα-SR, separately. Protein expression of N-
cadherin and total EGFR were all reduced in p65 shRNA and IκBα-SR HONE1 cells compared to scramble and pWPI-VA control. The (^) indicates the
exogenous 3xHA-IκBα-SR. (B)Western blot analysis of p65WT-overexpressing HONE1 cells showed increased acetylation at K310 and enhanced
phosphorylation at S536 compared to VA cells. The p65WT overexpression increases the protein levels of IκBα, snail, slug, twist, N-cadherin, and sox9,
compared to VA cells. The p84 was used as a loading control. The (✚) indicates the exogenous RFP-p65WT. The ($) indicates the acetylation band in the
exogenously expressed RFP-p65WT.
doi:10.1371/journal.pone.0127239.g004
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abilities of p65 are substantially reduced in LTBP2-expressing HONE1 and HK1 cells (Fig 6B).
These data are consistent with our earlier signaling pathway analysis (Fig 5A). To confirm the
loss of p65 transcriptional activity, expression levels of various NF-κB target genes were inter-
rogated. The panel of genes studied includes RelA (p65), NFKBIA (IκBα), TWIST1,MMP3,
SOX9, ICAM,MCAM, EGFR, and FN1. All target genes were shown to be significantly down-
regulated after re-expression of LTBP2 (Fig 6C). This suggests the importance of this candidate
tumor suppressor gene in the regulation of the NF-κB signaling.
LTBP2 suppresses cancer cell growth in vitro and in vivo
LTBP2 was examined to determine its functional role in NPC cells. In order to study the func-
tion of this protein of interest, a lentivirus expression system was established to re-express
LTBP2 in LTBP2-silenced NPC cells, HONE1 and HK1 (Fig 7A). Re-expression of LTBP2 in
NPC cell lines caused a reduction in the numbers and sizes of colonies in both 2D and 3D cul-
ture systems (Fig 7B and 7C). At an in vivo level, LTBP2 greatly suppressed the tumorigenicity
Fig 5. LTBP2 regulates the p65 signaling pathway. (A) Phosphorylated IKKα/β S176/180 and phosphorylated IκBα SS32/36 are also reduced in
LTBP2-infected cells. Phosphorylated p65 serine 536 level is reduced in LTBP2-infected cells compared to VA in HONE1 and HK1. The p84 and α-tubulin
were used as loading controls. (B)Matrigel plug tumors show a reduction in phosphorylated p65 S536 in LTBP2-transduced cells compared to VA. The p84
was used as loading control. (C) Subcellular fractionation results show that phosphorylated p65 S536 was reduced in the nuclear fraction of
LTBP2-transduced cells compared to VA. The p84 was used as control to determine nuclear fraction, while α-tubulin was used as the control for the
cytoplasmic fraction.
doi:10.1371/journal.pone.0127239.g005
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of HONE1 and HK1 NPC cell lines, giving rise to significantly smaller tumors compared to the
control group (Fig 7D). This further confirms the role of the NF-κB inactivation to suppress
NPC tumorigenesis.
LTBP2 exhibits regulatory roles in migration and angiogenesis
To assess whether LTBP2 also inhibited other hallmarks of tumorigenesis, the function of
LTBP2 in migration and angiogenesis was probed.
Re-expression of LTBP2 in NPC cells impeded its migratory potential as measured by the
wound healing assay (Fig 7E). To further substantiate our findings, an xCELLigence RTCA DP
analyzer was then utilized to quantify the degree of migration delay after re-expression of
Fig 6. LTBP2 regulates the translocation and activities of p65. (A) Immunofluorescence staining of phosphorylated p65 S536 (green fluorescence)
revealed weaker staining intensity as well as decreased nuclear staining in LTBP2-infected cells compared to VA. Nuclei were stained with 4, 5-diamidino-
2-phenylindole (DAPI, blue fluorescence). Scale bar represents 5μm. (B) NF-κB binding reporter assay showed reduced chemiluminescence intensity in the
nuclear fraction of LTBP2-transduced cells compared to VA in both HONE1 and HK1. Data represented on the bar graph are the average of triplicate
experiments ± S.E.M. (C) Real-time PCR of NF-κB target genes showed that the transcriptional activities of LTBP2-infected cells were reduced compared to
VA in both HONE1 (top) and HK1 (bottom). The panel of genes include: RELA, IκBα, TWIST,MMP3, SOX9, ICAM,MCAM, EGFR, and FN1.GAPDHwas
used as an internal control. The above data were obtained from three independent experiments done in duplicate and the (*) for all graphs indicate P-
value < 0.05.
doi:10.1371/journal.pone.0127239.g006
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LTBP2 in NPC cells. Results suggested that the re-expression of LTBP2 hampered the rate of
migration, when compared to VA-infected cells (Fig 7F).
The correlation of angiogenesis and the canonical NF-κB pathway has been well-docu-
mented in various cancers [2,42–48], including NPC [10,11,49,50]. The anti-angiogenic poten-
tial of LTBP2 was investigated. Conditioned media from the LTBP2-re-expressing NPC
HONE1 and HK1 cells (Fig 8A) decreased in vitroHUVEC tube-forming ability (Fig 8B). The
effect of LTBP2 in regulating angiogenesis in vivo was then determined by the standard nude
mouse matrigel plug assay. After staining the matrigel plugs with a blood vessel marker, CD34,
LTBP2 re-expression induced a distinct reduction in the relative numbers of microvessels (Fig
Fig 7. LTBP2 suppresses tumorigenic properties in vitro and in vivo. (A) Restoration of LTBP2 expression in HONE1 and HK1 cells using the lentiviral
system, as detected byWestern blot analysis. The p84 was used as a loading control. (B) 2D colony formation assay showed reduced number of colonies in
LTBP2-expressing cells compared to pLVX-VA cells. Bar graphs show the percentage difference between number of colonies in LTBP2 and VA cells ± S.E.
M. (C) 3D colony formation assay showed reduced number and size of LTBP2 cell colonies compared to VA. Percentage difference is represented by the bar
graphs ± S.E.M. (D) In vivo tumor growth kinetics of LTBP2 and VA HONE1 and HK1 cells. Each data point represents an average tumor volume of six
injection sites inoculated for each cell population ± S.E.M. (E)Wound healing analysis for HONE1 and HK1 cell lines showed delayed migration of
LTBP2-transduced cells compared to VA. Bar graphs show the percentage difference between LTBP2 and VA cells ± S.E.M. (F) Real-time monitoring of cell
migration using xCELLigence RTCA DP analyzer in LTBP2-transduced HONE1 and HK1 cells. The above data were obtained from three independent
experiments and the (*) for all graphs indicate P-value < 0.05.
doi:10.1371/journal.pone.0127239.g007
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8C). This can be explained by the down-regulation of various pro-angiogenic factors, IL6, IL8,
VEGF165 and 189, Total VEGF, ANG, TSP1, uPAR, PDGFB, RANTES, andMCP1 in
LTBP2-expressing cells (Fig 8D). Collectively, these data confirm the importance of LTBP2 in
suppressing tumor-associated angiogenesis in NPC through significant reduction of pro-
angiogenic factors.
The corollary of these findings indicates that the ECM LTBP2 protein plays crucial roles in
the tumor microenvironment and are implicated in the critical NF-κB p65 signaling cascade in
NPC.
Fig 8. LTBP2 reduces angiogenesis in vitro and in vivo. (A) Expression of secreted LTBP2 in conditioned media from HONE1 and HK1
LTBP2-transduced cells. Coomassie blue staining of total protein in conditioned media was used to indicate equal loading. (B) LTBP2-conditioned media
from HONE1 and HK1 cells suppressed the tube formation ability of HUVEC cultures. Bar graph represents an average of triplicate experiments ± S.E.M. (C)
Matrigel plug tumors were stained for CD34 to visualize the microvessels, as indicated by the black arrows. LTBP2-transduced cells displayed significantly
fewer microvessels in matrigel plugs compared to VA cells, as indicated by the bar graphs. (D) Real-time PCR of HONE1 (top) and HK1 (bottom) LTBP2- and
VA-transduced cells showed the down-regulation of angiogenesis-related genes with LTBP2 expression: IL6, IL8, VEGF 165, VEGF 189, total VEGF, ANG,
TSP1, uPAR, PDGB, RANTES, andMCP1. The housekeeping gene,GAPDH, was used as an internal control. The above data were obtained from three
independent experiments in duplicate and the (*) for all graphs indicate P-value < 0.05.
doi:10.1371/journal.pone.0127239.g008
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Discussion
NPC, one of the most common malignancies in the Southern China region, is hampered in its
diagnosis due to early age onset, obscure predisposition, and asymptomatic manifestations
[51,52]. Nonetheless, the EBV infection in NPC was singled out as a major etiological factor
with its undisputedly strong association between NPC and EBV [53–57]. This also highlights
the immunological implication of such virally-induced epithelial cancers, as observed by many
independent research teams over the years. Besides viral infection, other inflammatory stimuli
such as prolonged exposure to carcinogens and/or mutagens will also drive pathologic changes
in the tumor microenvironment that eventually promote tumor progression [8,9,58]. Chronic
inflammation leads to a prolonged surge in pro-inflammatory cytokine release, as well as fibro-
blast and leukocyte activation through the innate and adaptive immune system. This will then
stimulate the tumor microenvironment to undergo a complex cascade of molecular and biolog-
ical changes in the ECM. NF-κB is a key player in mediating inflammatory responses and regu-
lating key cytokines such as TNF-α, leading to cancer development [47,59–62]. Nevertheless,
the direct role of the canonical NF-κB p65 subunit in NPC has remained largely elusive. Thus,
we now provide in vitro and in vivo evidence of the importance of the p65 subunit in NPC.
Using the loss- and gain-of-function approaches, p65 was shown to play an important role
in regulating cell growth and angiogenesis. Since direct shRNA-mediated knockdown may re-
sult in possible off-target effects, potentially causing false-positive phenotypic changes to cells
[63,64], IκBα-SR and RFP-p65 WT were used to minimize off-target effects. IκBα-SR contains
two mutations at serines 32 and 36, where serines were replaced by alanines as S32A/S36A [65]
(S3A Fig). Thus, ubiquitination cannot occur at those two sites, resulting in a non-degradable
IκBα that can sequester p65 in the cytoplasm and inhibit its transcriptional activity [37,66].
p65 is a key driver of tumorigenicity in NPC
Aberrant manipulation of p65 expression has demonstrated that this transcription factor has
direct effects on tumor growth and angiogenesis. Moreover, p65 activation clearly induces
EMT, through the up-regulation of important EMT-related proteins such as Snail, Slug, Twist,
N-Cadherin, and Sox9 with tumor cells, also increasing aggressiveness and acquiring the ability
to metastasize. However, the p65 WT-overexpressing cells did not assume a fibroblast-like
morphology (data not shown). This may be due to a robust negative feedback mechanism ren-
dered by a marked increase in IκBα expression, and thus, hampering a complete morphological
change [37]. This postulation was further corroborated by silencing the IκBα, that later re-
sulted in complete EMT with the up-regulation of mesenchymal markers, down-regulation of
epithelial markers, and the induction of cell morphological changes. A change in morphology
is a typical characteristic of the EMT phenonmenon due to the loss of adheren junctions in the
cells, causing cells to elongate and then metastasize [67].
p65 is tightly regulated by the IκBα negative feedback mechanism and
important ECM proteins in NPC
While it seems imperative for p65 to mediate its function in the nucleus, the latest controversy
arises in NPC, due to the cytolocalization of p65. Ding et al. [68] showed detectable levels of
nuclear phosphorylated p65 S536 with and without LMP1 and IκBα-SR induction. However,
the lack of nuclear p65 IHC staining in NPC was reportedly correlated with poor prognosis of
NPC [11]. Incidentally, they showed that cytoplasmic p65 was found in 100% of NPC clinical
samples. Moreover, by knocking down the apparent cytoplasmic p65, the team also saw a sup-
pression of cell migration and invasion abilities through reduced MMP9 expression and
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activity [49]. In contrast, the non-canonical NF-κB pathway is known to be constitutively ac-
tive in NPC. RelB, Bcl3, and p50 were highly up-regulated, with both Bcl3 and p50 directly
influencing EGFR expression [69–71].
Nevertheless, the direct roles of p65 in NPC have yet to be fully characterized. This current
study provides evidence for the acetylation of the lysine K310 site on p65, as an indication of a
fully trans-activated p65, when p65 WT is overexpressed. Detecting the acetylation on K310 is
technically challenging, due to low basal level of this acetylation in our cell line system. Despite
eliciting several cellular events with p65 WT over-expression, nuclear translocalization of p65
is rather infrequent and barely detectable. Our results are, therefore, in line with the findings
that overexpressed p65 WT remains largely cytoplasmic [72]. Whether the nuclear transloca-
tion of p65 is necessary for oncogenic function, we deduce that a minor fraction of fully activat-
ed acetylated-K310 p65 WT can still enter the nucleus, and induce subsequent downstream
gene expression of N-Cadherin, Twist, Slug, Snail, and Sox9. Consequently, we theorize that a
trace amount of nuclear p65 is sufficient to promote tumorigenicity; p65 may have cytoplasmic
functions that favor the cytoplasmic retention of p65 in NPC; cytoplasmic p65 expression is
correlated with NPC progression; de novo expression of IκBα is an instant feedback mecha-
nism that efficiently inactivates p65 in a temporal and spatial manner. These hypotheses are
currently being tested in the lab.
In addition, the ECM proteins also play an important role in p65 regulation. Loss of vital
ECM tumor suppressor genes alters the tumor microenvironment and promotes tumor growth
and tumor-associated angiogenesis by modulating the intrinsic nuclear trafficking of the p65
subunit. Previously, we identified an ECM protein, LTBP2, as a candidate tumor suppressor in
NPC. In-depth findings later confirmed that LTBP2 modulated the nuclear translocation of
p65 and was particularly involved in anti-angiogenesis via the p65 signaling cascade. Secretion
of pro-angiogenic cytokines by the tumor cells themselves remains germane for the sustenance
of tumor-associated angiogenesis [73]. Hence, re-expression of LTBP2 ultimately led to a de-
creased expression of pro-angiogenic cytokines by NPC cells. Correspondingly, the anti-angio-
genic effects induced by p65 inactivation approaches are akin to the re-expression of LTBP2.
The down-regulation of these p65-mediated angiogenic factors: VEGF,MCP1, PDGFB,
RANTES, IL6, and IL8, have all been widely reported [74–78].
More importantly, the analysis of LTBP2 in tumor biopsies may hold potential prognostic
or diagnostic value in a clinical perspective. We can postulate that the loss of LTBP2 may be
one of the genetic hits in carcinogenesis based on the Knudson’s two-hits hypothesis [79]. Nev-
ertheless, ongoing research is being conducted to validate this hypothesis
Finally, since NF-κB is primarily involved in the immunological signaling cascade mechanism
originally found in B cells and T cells, the conundrum between these ECM proteins and their im-
plication on tumor immunology and the microenvironment was investigated. Transcriptional ac-
tivation of NF-κB requires various upstream signaling stimulants. In this study, we determined
the potential role of LTBP2 in regulating the NF-κB signaling cascade, particularly, the canonical
p65 pathway. Our results showed that both proteins down-regulate the canonical p65 pathway
through an as yet unknownmechanism. Additionally, LTBP2 exhibiting their anti-tumorigenic
functions through the reduction of the active p65 transcription factor, was similar to the func-
tional characteristics of p65 in NPC. In conclusion, the NF-κB p65 signaling pathway plays an
important role in NPC development and provides potential therapeutic targets for NPC.
Supporting Information
S1 Fig. Inactivation of p65 in NPC cell lines. (A) Domain structure of IκBα-SR and IκBα are
illustrated using the SMART 7 domain structure prediction tool. The mutations at serines 32
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and 36 are shown in red (B) Real-time qPCR analysis of p65-related angiogenic genes include:
RELA, NFKBIA, IL6, IL8, RANTES,MCP1, VEGF165, VEGF189, and Total VEGF. GAPDH
was used as an internal control. p65 shRNA cells displayed reduced angiogenic gene expression
compared with scramble control cells. (C) Quantitative PCR analysis of other p65-related NF-
κB genes include:MMP3, SOX9, ICAM,MCAM, EGFR, and FN1. GAPDH was used as an in-
ternal control. p65 shRNA cells showed decreased expression of these genes compared to the
scramble control cells. (D) Confocal microscopy of IκBα-SR transduced HONE1 cells showed
the cytolocalization of exogenous and endogenous IκBα, mainly in the cytoplasmic region of
the cells (red fluorescence staining). Scale bar represents 1μm.
(TIF)
S2 Fig. Quantitative PCR analysis of angiogenesis-related genes in IκBα shRNA-mediated
transient knockdown HONE1 cells. Angiogenic genes include: IL6, IL8, Total VEGF,
VEGF165, VEGF189, PDGFB, andMCP1. GAPDH was used as an internal control. IκBα-
shRNA HONE1 cells displayed an overall increase in angiogenic markers, with significantly
higher expression of IL6 and IL8 cytokines compared with scramble control cells.
(TIF)
S3 Fig. IκBα shRNA-mediated transient knockdown HONE1 cells undergo epithelial-mes-
enchymal transition (EMT). (A) Quantitative PCR analysis of EMT-related genes Fold-differ-
ences of the gene expression were compared to the scramble control. EMT genes include: E-
cadherin, α-Catenin, β-catenin, N-cadherin, Slug, Snail, Twist, Vimentin, SM-Actin, and Sox9.
GAPDH was used as an internal control. IκBα-shRNA HONE1 cells down-regulated the ex-
pression of epithelial markers (E-cadherin, α-Catenin and β-catenin), while inducing the ex-
pression of mesenchymal markers (N-cadherin, Slug, Snail, Twist, Vimentin, SM-Actin, and
Sox9). (B)HONE1 brightfield microscopic images of scramble control and IκBa-shRNA cells
at 40x magnification. Scale bar represents 10μm.
(TIF)
S1 Table. shRNA oligonucleotide sequences.
(PDF)
S2 Table. Primary antibodies used in the study.
(PDF)
S3 Table. Gene-specific primers used in the study.
(PDF)
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